Research and Markets has announced the addition of the "Phase II/III Study Trends and Market Outlook (2016-2020)" report to their offering.
For this report, 112 Phase II/III decision-makers were surveyed to gather their insights into where the Phase II/III market is expected to head over the next four years. This report is designed to assist those interested in the Phase II/III market in not only remaining current with market happenings but in getting a jump on what the market is expected to look like in 2020.
What You Will Learn:
- 4-year examination of the industry's Phase II/III market dynamics (i.e. study volume, outsourced spend)
- Average dollar value of outsourced Phase II/III studies and how this varies by sponsor size
- Criteria sponsors use to select (and disqualify) clinical service providers
- Current and future use of adaptive trials and risk-based monitoring in Phase II/III trials
How you can use this report:
- Gain understanding of the key decision-makers within sponsor organizations to develop more targeted communications
- Learn the most desirable characteristics of a Phase II/III service provider
- Discover the expansion into developing markets
Key Topics Covered:
1. Introduction
2. Methodology
3. Respondent Demographics & Qualifications
4. Study Data
Respondent Demographics
- Company Type
- Areas Of Responsibility
- Drug Development Responsibilities
- Respondent Location
- Job Title
- Recent Outsourcing Involvement
- Drug Development Involvement
- Drug Development Involvement By Phase
For more information about this report visit http://www.researchandmarkets.com/research/36svsg/phase_iiiii
View source version on businesswire.com: http://www.businesswire.com/news/home/20170126005828/en/